Navigation Links
Linden Capital Partners Completes Acquisition of Young Innovations, Inc.
Date:1/31/2013

ST. LOUIS, Jan. 31, 2013  /PRNewswire/ -- Young Innovations, Inc. ("Young" or the "Company") today announced the completion of its acquisition by affiliates of Linden Capital Partners ("Linden") in an all-cash transaction valued at approximately $314 million.

As previously announced, the transaction was approved by Young shareholders at a special meeting of shareholders held January 30, 2013. Pursuant to the terms of the agreement and plan of merger, Young's shareholders are entitled to receive $39.50 in cash, without interest, less any applicable withholding taxes, for each share of Young common stock owned by them. As a result of the acquisition, Young's common stock will no longer be listed for trading on NASDAQ.

Shareholders of record will receive a letter of transmittal and instructions on how to surrender their shares of Young common stock in exchange for the merger consideration. Shareholders of record should wait to receive the letter of transmittal before surrendering their shares.

Robert W. Baird & Co. Incorporated served as financial advisor, and provided a fairness opinion, to the Board of Directors of Young in connection with the transaction. McDermott Will & Emery LLP served as legal advisors to Young in connection with the transaction. Kirkland & Ellis LLP served as legal counsel to Linden in connection with the transaction.

About Young Innovations, Inc.:

Young develops, manufactures and markets supplies and equipment used by dentists, dental hygienists, dental assistants and consumers. The Company's consumables product offering includes disposable and metal prophy angles, prophy cups and brushes, dental micro-applicators, moisture control products, infection control products, dental handpieces (drills) and related components, endodontic systems, orthodontic toothbrushes, flavored examination gloves, children's toothbrushes, and children's toothpastes. In addition, the Company offers a line of diagnostic products that includes panoramic X-ray machines and related supplies. The Company believes it is a leading U.S. manufacturer or distributor of prophy angles and cups, liquid surface disinfectants, dental micro-applicators and obturation units designed for warm, vertical condensation.

About Linden Capital Partners:

Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden's strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden currently has investments in middle market platforms in the products, distribution, and services segments of healthcare.


'/>"/>
SOURCE Young Innovations, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Young Innovations Announces Definitive Agreement to be Acquired by Linden Capital Partners
2. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
3. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
4. Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan
5. Topokine Therapeutics Secures Financing from Schooner Capital to Advance Clinical Development of XAF5 Gel
6. American Capital Receives $60 Million From The Sale Of Lifoam Holdings And Generates An 11% Return On Its Investment
7. BioScrip To Present At "NINE" Noble Financial Capital Markets Ninth Annual Equity Conference
8. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
9. Unisense FertiliTech A/S Secures 24 Million USD in New Capital Investment
10. Kerry R. Hicks Joins Physicians Capital Investments as Vice-Chairman of Board
11. DePuy Settlement Funding And Transvaginal Mesh Capital Increased At Legal-Bay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
(Date:9/7/2017)...  Eli Lilly and Company (NYSE: ... to more efficiently focus resources on developing new ... workforce reductions, including those from a U.S. voluntary ... 3,500 positions. With the streamlining ... approximately $500 million that will begin to be ...
Breaking Medicine Technology:
(Date:9/26/2017)... ... 2017 , ... After a summer-long contest to crown the ... Drivers proudly announced the winners of the HEROtini Mocktail Challenge at the Stockton ... the challenge of competing in three categories: Best HEROtini Mocktail, Top HEROtini Bartender, ...
(Date:9/26/2017)... ... , ... Data Integrity: , The Key to FDA and GMP Compliance, ** ... http://www.fdanews.com/fdadataintegrity , Consider this situation. The FDA gives simple ... be trustworthy and reliable … a more detailed evaluation may be warranted.” , ...
(Date:9/26/2017)... ... 26, 2017 , ... Dr. Kovatis, is a Hospital for ... and Foot Section of the Department of Orthopedic Surgery at Hackensack University Medical ... UMC performing total ankle replacements. Because of this, Dr. Kovatis is often referred ...
(Date:9/26/2017)... , ... September 26, 2017 , ... The 2017 American ... called “The Magic of Fat,” revealed not only the latest about cosmetic procedures to ... be an evolution in cosmetic medicine. , “Fat really is magical, especially when it ...
(Date:9/26/2017)... ... 26, 2017 , ... The Organizing Committee is pleased to ... Pittcon 2018. As of July 1, Adrian C. Michael, Ph.D. (University of Pittsburgh, ... Charles Gardner, (ChemImage Corporation) and selected chairs. , Other members of ...
Breaking Medicine News(10 mins):